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While dendritic cells (DC) are central to the induction and regulation of adaptive immunity,
these cells are very heterogenous and speciﬁc subsets can be characterized based on the
expression of cell surface markers and functional properties. Intestinal CD103+ DCs are
the subject of particular interest due to their role in regulating mucosal immunity. Since
the epithelial surfaces are constantly exposed to a high antigenic load, tight regulation of
innate and adaptive intestinal immune responses is vital as intestinal inﬂammation can have
detrimental consequences for the host. Strategically positioned within the lamina propria,
CD103+ DCs play an important role in maintaining intestinal immune homeostasis. These
cells are required for the induction of tolerogenic immune responses and imprinting gut
homing phenotypic changes on antigen-speciﬁc T cells. Recent insights into their devel-
opment and regulatory properties have revealed additional immunoregulatory roles and
further highlighted their importance for intestinal immunity. In this review we discuss the
nature of the intestinal CD103+ DC population and the emerging roles of these cells in the
regulation of mucosal immunity.
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INTRODUCTION
The epithelial surfaces of the body are constantly exposed to a
wide variety of antigenic material, ranging from dietary proteins
and commensals to pathogenic bacteria, viruses, and allergens.
These antigens are separated from the delicate underlying body
surfaces by a thin layer of cells, the epithelium. The cells and tis-
sues comprising the mucosal immune system are located in the
gastrointestinal tract (GIT), the upper and lower respiratory tracts
and the urogenital tract. It also includes exocrine glands associ-
ated with these organs, such as the pancreas, the conjunctive and
lacrimal glands of the eye, the salivary glands, and the lactating
breast. The GIT and respiratory mucosa are the main portals of
pathogen entry and therefore the generation of effective immune
responses at these surfaces is vital to prevent infection. However,
various regulatory mechanisms must also be in place to prevent
damaging inﬂammatory reactions from occurring against benign
antigens. There is increasing evidence that the dendritic cell (DC)
populations located at these sites are vital in the maintenance of
this immunological balancing act.
INTESTINAL DENDRITIC CELLS
The intestinal mucosa is home to many cells of the mononu-
clear leukocyte family, including macrophages and DCs which are
strategically positioned for antigen capture, and it is now well
established that they play a vital role in orchestrating intesti-
nal immune responses (Kelsall, 2008). DCs are potent antigen-
presenting cells (APC) and are key modulators of the immune
response, due to their ability to process and present antigens to
T cells. Intestinal DCs are essential for the activation of inﬂam-
matory pathways and maintaining local immunological tolerance.
Initially described by Steinman and Cohn (1973), an increasing
number of DC subtypes have been identiﬁed and characterized.
Dendritic cells are enormously plastic in nature, owing to vari-
ous microenvironmental adaptations and inﬂuences. Despite their
heterogeneity, these cells share functional properties that distin-
guish them as a pivotal link between the innate and adaptive
immune system (del Rio et al., 2010). DCs are located through-
out the intestine, including the lamina propria (LP) of both the
small and large intestine, peyers patches (PP), draining mesenteric
lymphnodes (MLNs), and at isolated lymphoid follicles (Rescigno
and Di Sabatino, 2009). Recent work by Merad and colleagues
has revealed the presence of CD11chighMHC class IIhigh DCs
within both the intestinal epithelial cell (IEC) fraction and LP,
meanwhile these cells were absent from both the serosal and
muscularis layers. These cells were further characterized into two
distinct populations,CD11chighMHCclass IIhighCD103+CD11b+
and CD11chighMHC class IIhighCD103−CD11b+ (Figure 1).
The majority of CD11chighMHCclassIIhigh DCs in the small
intestinal LP (SI-LP) express the CD103 integrin and have distinct
functional properties (del Rio et al., 2008). These cells are also
foundwithin the PPs (Jaensson et al., 2008), colonic LP and (MLN;
Johansson-Lindbom et al., 2005). Immunoﬂuorescence studies
have revealed the presence of CD103+CD11c+ DCs in the LP
and within the intraepithelial space of the apical villi, in contrast
CD103−CD11b+ DCs accumulated mainly in the LP (Bogunovic
et al., 2009).
The T-epithelial cell associated integrin CD103, also known
as the αEβ7 integrin was discovered in the late 1980s as human
mucosal lymphocyte antigen HML-1 (Cerf-Bensussan et al., 1987)
and its functional role was described in 1994 (Cepek et al., 1994).
Integrins are a large groupof transmembraneαβheterodimers that
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FIGURE 1 | Characterization of CD103+ DC subsets in the small bowel.
With permission (Bogunovic et al., 2009). Single cell suspensions were
prepared from various anatomical locations found throughout the small
bowel, these included the IEC compartment, lamina propria (LP), serosa
with the intestinal muscularis, and PP. The populations were gated on DAPI
negative, CD45 positive, MHC Class IIhigh and CD11chigh. The CD11chigh
population was further characterized on the basis of CD103 and CD11b
expression.
mediate cell to cell binding and cell to extracellular matrix interac-
tions and are vital for T cell homing, cell signaling, adhesion and
migration (Dustin et al., 1989; Springer, 1994, 1995). The CD103
integrin is expressed as a heterodimer with its β7 chain partner
(Kilshaw and Murant, 1990).
In addition to its expression on mucosal CD11chighMHCIIhigh
DCs, CD103 is also expressed on a subset of effector memory
CD8+ T cells in addition to subsets of CD4+ andCD8+ regulatory
(Treg)T cells (Lehmann et al., 2002;Uss et al., 2006). The principal
ligand for CD103 is E-cadherin, expression of which is conﬁned
to the basolateral surface of epithelial cells and is not detected on
endothelial cells. CD103 has also been shown to be responsible
for inﬂuencing cellular shape and motility in a ligand-dependent
fashion (Schlickum et al., 2008).
ORIGINS AND DEVELOPMENT OF THE INTESTINAL CD103+
DC POPULATION
Dendritic cells within the intestinal compartments have been
extensively studied and much is now known regarding their phe-
notype. CD11c+ MHC class II+ DCs have been shown to be
present in the LP and IEC fraction and were absent from the
muscularis and serosa. The LP is home to two distinct DC subsets;
CD11chighMHC class IIhighCD103+CD11b+CX3CR1−M-CSFlow
(CD103+CD11b+) and CD11chighMHC class IIhighCD103−
CD11b+CX3CR1+M-CSFhigh (CD103−CD11b+) DCs. Mean-
while the PPs are home to CD11chighMHC class IIhighCD103+
CD11b−CX3CR1− (CD103+CD11b−)DCs. CD11clowMHCclass
IIhighCD103−CD11b+ DCs are found throughout the muscular
and serosal layers of the gut, with equivalent populations found in
the large bowel (Bogunovic et al., 2009).
Granulocyte-macrophage–colony-stimulating factor (GM–
CSF) and Fms-like tyrosine kinase 3 (Flt3) ligand are two impor-
tant cytokines involved in DC development (Merad and Manz,
2009). In contrast, the development of macrophage populations
in addition to epidermal Langerhans cells requires ligands for
the macrophage colony stimulating factor receptor (M-CSFR;
Ginhoux et al., 2006). Given the key role of M-CSFR ligands
in the development of these populations, there may also be a
role for these factors in the development of intestinal DCs. In
fact, the development of CD103−CD11b+ LP DCs was dra-
matically affected following the selective deletion of M-CSFR
(Csf1r−/−), whereas the CD103+CD11b+ population was unaf-
fected. Flt3 is required for the development of both popula-
tions of LP–DCs, with a stronger requirement in the case of
the CD103+CD11b+ cells. CD103+CD11b+ DCs also require
GM–CSF for their development unlike the CD103−CD11b+ DC
population.
Common DC precursor (CDP) and pre-DC do not con-
tribute substantially to the CD103−CD11b+ LP–DC popula-
tion under steady state conditions while monocytes actively dif-
ferentiate into CD103−CD11b+ LP–DCs. However, Bogunovic
et al. (2009) revealed that the GM–CSFR is dispensable for
CD103− DC differentiation but is required for the differentia-
tion of CD103+CD11b+ and CD103+CD11b− DCs (Bogunovic
et al., 2009). Research also suggests that although the CD103+
population expresses CCR7 and actively migrate during steady
state conditions, the CD103− DCs appear to be a resident non-
migrating population in the MLN. In fact, only approximately
20% of the MLN CD103− DCs express CX3CR1, suggesting
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a different developmental origin than LP CD103− DCs, which
express CX3CR1.
CD103 DCs PROMOTE INTESTINAL T CELL HOMING
CD103+ DCs in the MLN have the unique ability to induce gut
homing phenotypic changes (Annacker et al., 2005; Johansson-
Lindbom et al., 2005). These cells are responsible for the upregu-
lation of C-C chemokine receptor type 9 (CCR9) and α4β7 expres-
sion on CD8+ T cells. These cell surface markers are essential for
the active migration of cells to peripheral non-lymphoid tissues.
Induction of CCR9 and α4β7 expression was initially observed fol-
lowing the co-culture of MLN CD103+ DCs from the MLN with
T cells after oral antigen administration. In contrast, these cells
failed to induce CCR9 and α4β7 expression on T cells following
intraperitoneal (IP) antigen injection. Agace and colleagues trans-
ferred TCR transgenic ovalbumin (OVA) speciﬁc OT-I cells into
recipient mice and the expression of CCR9 and α4β7 in the MLNs
was examined 3 days following IP or oral antigen administration.
CCR9andα4β7 endowed thenewly activatedT cellwith the capac-
ity to migrate to the small intestine and exert effector functions
(Annacker et al., 2005; Johansson-Lindbom et al., 2005).
The vitamin A metabolite, retinoic acid (RA), has been shown
to be responsible for the induction of CCR9 and α4β7 expression
onT cells (Iwata et al., 2004). RA conversion depends on retinalde-
hyde dehydrogenases (RALDH), which are expressed on MLN
DCs as well as stromal cells. Despite expression of RALDH2 by
both the CD103+ and CD103− MLN DCs, MLN and LP CD103+
DCs express much higher levels of the enzyme than their CD103−
counterparts (Coombes et al., 2007). While CD103− DC in the
MLN retain the capacity to prime CD4 and CD8 responses, these
cells lacked the ability to induce gut homing signatures on naïve
T cells (Annacker et al., 2005; Johansson-Lindbom et al., 2005)
highlighting the unique role of the CD103+ DC subset.
A recent exciting development has linked bile retinoids to the
imprinting of LP CD103+ DCs in the small intestine, which
have the ability to generate gut homing T cells. Agace and col-
leagues demonstrated that the imprinting of CD103+ DCs is
itself dependent on vitamin A and occurs locally within the small
intestine, with high levels of retinol being detected within the
bile (Jaensson-Gyllenback et al., 2011). The authors found that
RA induced retinol-metabolizing activity in DCs both in vivo
and in vitro. CD103+ DCs in the small intestinal LP con-
stantly receive RA signaling in vivo at much higher levels than
colonic CD103+ DCs. In a series of elegant experiments it was
revealed that small intestinal CD103+ DCs remained imprinted
in mice following the depletion of dietary but not systemic retinol
(Jaensson-Gyllenback et al., 2011).
REGULATION OF IMMUNE RESPONSES BY CD103+ DC
A number of regulatory mechanisms are employed by the immune
system to maintain local immune homeostasis, prevent autoim-
munity and control inﬂammation (Mills, 2004). Treg cells are
regarded as the primary mediators of peripheral tolerance and
are vital in the prevention of chronic inﬂammatory conditions.
It is now ﬁrmly established that there are two groups of Treg
cells. These natural (or constitutive) and inducible (or adaptive)
Treg cells are believed to have overlapping and complementary
functions in the control of the host immune response. Natural
Treg (nTreg) cells, which are characterized by the expression of
CD4 and CD25, are functionally mature upon leaving the thy-
mus. Initially described by Sakaguchi et al. (1995), these cells leave
the thymus and mediate peripheral tolerance by suppressing self-
reactive T cells (Bluestone and Abbas, 2003; Cozzo et al., 2003).
The transcription factor FoxP3 is the most deﬁnitive marker for
Treg cells in both humans and mice (Powrie et al., 1996; Shimizu
et al., 2002; Fontenot et al., 2003).
In contrast to nTregs, induced Tregs (iTreg) cells are derived
from mature CD4+ T cells found in the periphery which develop
into iTregs following antigen stimulation and/or co-stimulation
from APCs. Furthermore, the development of these cells may also
be inﬂuenced by the presence of exogenous cytokines. iTregs can
be categorized into subsets including Tr1, Th3 and CD8+ sub-
sets, which can be deﬁned based on cytokine expression (Haynes
et al., 2000; Garba et al., 2002). Unlike nTregs, iTregs are speciﬁc
for antigens, which are not encountered within the thymus during
the process of central tolerance. Due to their importance in main-
taining immune homeostasis, inducible antigen-speciﬁc Tregs are
now being targeted in clinical trials in order to treat a number of
autoimmune diseases. In addition to their ability to induce gut
homing, CD103+ DCs can induce the development of iTreg cells
thereby mediating tolerance (Coombes et al., 2007).
The GIT is constantly exposed to a wide variety of antigenic
material and maintenance of the local homeostasis in the gut
stretches the discriminatory powers of the immune system to its
limits (Wright, 2005). Although the vast majority of incoming
antigens are harmless, some are highly immunogenic and have a
propensity to induce inﬂammation, highlighting the importance
of regulatory mechanisms in the gut. The GI mucosal immune
system must carry out the difﬁcult task of discriminating between
the background antigenic noise and the much rarer signals trans-
mitted by pathogens and their associated antigens. One strategy
to prevent inﬂammation is the positioning of DCs in these com-
partments to capture and process antigens, and induce tolerance.
Iliev et al. (2009) revealed that CD103+ DCs induce tolerance
and gut homing, protecting against experimentally induced colitis
in mice. CD103+ DCs exerting tolerogenic effects has been fur-
ther suggested by the recent ﬁnding the CD11c+CD103+ DCs are
decreased in the celiac lesion during celiac disease (Beitnes et al.,
2011).
Mesenteric lymphnode CD103+ DCs mediate the conversion
of naïve T cells to FoxP3-expressing T cells by producing TGF-β
and RA (Coombes et al., 2007).When MLN DCs loaded with OVA
were cultured in the absence of TGF-β, CD103+ DCs induced the
development of antigen-speciﬁc iTreg cells. Furthermore,CD103−
DCs failed to induce Treg development (del Rio et al., 2010), and it
was suggested that “the special capacity of MLN-derived CD103+
DCs to drive iTreg cell differentiation may relate to the abun-
dant expression of tissue plasminogen activator, TGFβ2, and latent
TGF-β binding protein 3.” Both TGFβ2 and latent TGF-β bind-
ing protein 3 are required for the activation and active secretion
of TGF-β. Upon addition of TGF-β, much higher levels of iTregs
were induced by the CD103+ DC than the CD103- population.
In addition to TGF-β, RA produced by CD103+ DCs is an
essential cofactor for increasing the rate of iTreg cell induction.
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FIGURE 2 | Mechanisms of antigen sampling by lamina propria DC
populations under steady state conditions. DCs can capture antigenic
material (including bacteria and other antigens) from the luminal
compartment via direct transport through the M cell. CX3CR1+ cells can
samples antigens directly by extending their dendrites into the luminal
compartment. This is achieved due to the ability of the CX3CR1+ cell
population to open the tight junctions between epithelial cells. CD103+
CX3CR1− DCs actively migrate to the mesenteric lymph nodes under
steady state conditions; these cells are responsible for the induction of
antigen-speciﬁcTreg cells. Moreover these cells are also responsible for the
induction of gut homing phenotypic changes, such as up regulation of
CCR9 and α4β7 onT cells. Antigens can also be captured by the underlying
immune cells via breaches in epithelial integrity (not shown) and by direct
transport via the fetal Fc receptor (not shown).
In fact, preincubation of DCs with a synthetic RA inhibitor pre-
vented the induction of iTreg cells (Coombes et al., 2007). iTreg
cells induced via the co-culture of CD103+ and CD4+ T cells were
capable of directly suppressing the proliferation of CD4+ T cells
under in vitro culture conditions (Annacker et al., 2005).
Recent reports have also suggested a role for indoleamine 2,3-
dioxygenase (IDO) in CD103+ DC-mediated iTreg cell induction.
It was shown that CD103+ DCs but not CD103− DCs expressed
IDO whose inhibition resulted in reduced CD4+FoxP3+ Treg
cell conversion and enhanced T cell proliferation (Matteoli et al.,
2010). Genetic deletion of IDO resulted in an increase in proin-
ﬂammatory Th1 and Th17 cells and moreover IDO depletion
results in the blockage of Treg cell induction and exacerbation
of colitis in mice (Matteoli et al., 2010).
In contrast to the suppressive role of CD103+ DCs, CD103−
DCs isolated from the MLN are associated with the production of
proinﬂammatory cytokines. Upon stimulation with LPS or R848,
CD103− DCs produced signiﬁcant concentrations of TNF-α and
IL-6 (Coombes et al., 2007). The CD103− population may be
derived from a recruited blood–borne precursor and as a result
do not undergo conditioning by the immune suppressive gut
microenvironment. In fact it has been shown that IEC induce
the expression of CD103 on the surface of DCs (Iliev et al., 2009)
and thereby promote their development.
New evidence has also revealed that inﬂammation directly
dampens the tolergenic ability of the MLN CD103+ DC pop-
ulation. This effect on the MLN CD103+ DC population was
mediated by a down-regulation of the tgf β2 and aldh1a2 genes
in the DC. MLN CD103+ DCs isolated from colitic mice had an
impaired ability to induce FoxP3+ Treg cells; in contrast these
cells had an enhanced ability to prime CD4+ T IFN-γ producing
T cells (Laffont et al., 2010). Laffont et al. (2010) also revealed
that CD103+ cells from naïve mice and mice with induced colitis
share the same developmental pathway. Furthermore, it has also
been revealed that CD103 expression is lost from the surface of
gut resident DCs during colitis (Strauch et al., 2010). These ﬁnd-
ings highlight the role of environmental inﬂuences in directing the
tolerogenic properties of these cells.
Under normal physiological conditions, the intestinal immune
system is tolerant to food antigens as well as to local commen-
sal bacteria; break down of this tolerance can result in severe
inﬂammatory reactions. It is therefore assumed that CD103−
DCs are poised to respond to pathogenic insult, while CD103+
DCs are responsible for the induction of Treg cells and hence the
maintenance of intestinal homeostasis.
It has been suggested that perhaps the resident gut-conditioned
DCs favor the development of tolerogenic immune responses,
whereas newly recruited inﬂammatory CD103− DCs may drive
protective immunity.
THE MIGRATORY ABILITY OF CD103+ DC
The M cell provides a major route of antigen entry across the
intestinal epithelium. M cells are specialized epithelial cells that
commonly reside in the follicle-associated epithelium overlying
the PPs (Azizi et al., 2010). M cells take up antigens by endo-,
phago-,or pinocytosis and transcytosis (Gebert et al., 2000),before
delivering them to the underlying immune cells.
In 2001,Rescigno et al. (2001) proposed anM cell-independent
pathway for antigenuptake (Rescigno et al.,2001). Previous studies
had revealed that Salmonella typhimurium, lacking genes encoded
on the pathogenicity island 1 (SPI1) that are necessary for invasion,
were observed within the spleen following oral administration
(Galan and Curtiss, 1989). Rescigno et al. (2001) revealed the
ability of resident intestinal DCs to open tight junctions between
epithelial cells and extend their dendrites into the epithelium and
directly sampling bacteria (Figure 2). Interestingly, because DCs
express the tight junction proteins zonula, occludin and claudin I,
the integrity of the epithelial barrier is preserved, preventing the
development of overt inﬂammatory reactions to intestinal bacte-
ria (Rescigno et al., 2001). Further work utilizing transgenic mice
which express GFP under the control of CX3CR1, demonstrated
that this chemokine receptor was vital for the development of
transepithelial dendrites, enabling these cells to directly sample
antigens from the lumen (Niess et al., 2005).
Regarding the CD103+ DC population, it now appears that
these cells are distinct from the CX3CR1-expressing population
within the LP. Despite the fact the CX3CR1 DC population out-
numbers the CD103+ DCs, CD103+ DCs selectively localize close
to the epithelium(Schulz et al., 2009). These cells also differ in their
ability to respond to growth factors and have different turnover
rates (Schulz et al., 2009), suggesting that they are derived from
very distinct precursors. Schulz et al. (2009) elegantly revealed
that in mice lacking CX3CR1, the LP CD103+ DC population
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are the main migratory population moving to the MLNs. Mean-
while the CX3CR1high LP cells may represent a non-migratory
tissue resident population (Schulz et al., 2009). Evidence also
suggests that the CD103+ DCs are much more potent at induc-
ing intestinal T cell responses compared to the CX3CR1int and
CX3CR1high populations, highlighting their importance. These
populations also differed in their ability to generate RA. CX3CR1+
DCs expressed much lower levels of aldha1a2 and as a result were
inefﬁcient at inducing the upregulation of CCR9 on T cells. It has
been postulated that perhaps CX3CR1+ LP DCs engulf luminal
bacteria (Niess et al., 2005) and take up orally administered anti-
gens (Schulz et al., 2009) before directly passing these antigens to
CD103+ LP DCs, which migrate to the MLNs where they mediate
tolergenic immune responses. However this has yet to be observed
experimentally. Impairment of DC trafﬁcking to the MLNs in
mice lacking the CCR7 receptor results in defective induction of
tolerance to oral antigens (Worbs et al., 2006), therefore establish-
ing the importance of continual antigen transport to the MLNs
in maintaining normal mucosal integrity. This was further high-
lighted by Varol et al. (2009) they determined that when mice
display only CD103−CX3CR1+ DCs, they are more susceptible to
dextran sodium sulfhate (DSS)-induced colitis (Varol et al., 2009).
CONCLUSIONS AND FUTURE PERSPECTIVES
Dendritic cells are essential modulators of the immune system
as they maintain the balance between immunogenic and tolero-
genic immune responses in the intestine. Dysregulation of DC
function as a result of environmental cues or genetic mutation
can result in severe intestinal inﬂammation. Despite extensive
recent research into intestinal DCs, many questions remain such
as: “are the progenitor cells intrinsically committed to becoming
CD103+ or CD103− DCs?” and are these linage commitments
dependent on local microenvironmental inﬂuences? The answer
to the latter question appears to be yes. Bogunovic et al. (2009)
have demonstrated the association of CD103+ DCs with epithelial
cells and luminal bacteria may play a role in CX3CR1 pheno-
typic differentiation, as shown by the fact that bacteria-derived
ATP is involved in the development of Th17-cell-inducing DCs
(Atarashi et al., 2008). Therefore environmental conditioning may
be essential for CD103+ and CD103− DC differentiation. The so
called “specialized division of labor” (Helft et al., 2010) between
the CD103+ and CD103− DC populations in the intestine has
yet to be fully substantiated with many fascinating new aspects
of biology of CD103+/CD103− DCs emerging. With the discov-
ery that CD103+ DCs mediate gut homing and induce Treg cell
development. CD103+ DCs may provide a novel therapeutic tar-
get to induce the expansion of Treg cells in the intestine. Targeted
delivery of antigens responsible for celiac disease, IBD and other
autoimmune diseases to intestinal CD103+ DCs may result in the
expansionof antigen-speciﬁcTregs thatmediate tolerance.Despite
many advances in DC biology, more in-depth insights into the
intestinal CD103+ DC subpopulation are required before their
therapeutic potential can be optimally determined.
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